植物衍生化合物的炎症药理学观点:与病毒受体的相互作用
1Department of Mathematics and Science Education, Science Education, Education Faculty, Kırıkkale University, Kırıkkale, 71450, Turkey. akgokalp@gmail.com.
Inflammopharmacology
|September 27, 2025
概括
天然化合物,如 Cucurbitacin I,通过与其受体相互作用,显示出对麻疹病毒 (MPXV) 的强大潜力. 这些发现表明了针对病毒病理和炎症的基于植物化学的新策略.
科学领域:
- 药理学和病毒学
- 计算化学的计算化学
- 自然产品化学 自然产品化学
背景情况:
- 病毒 (MPXV) 构成了严重的公共卫生威胁.
- 需要针对MPXV的新型治疗策略,特别是具有免疫调节和抗炎性能的治疗策略.
- 药用植物是生物活性化合物的丰富来源,具有潜在的治疗应用.
研究的目的:
- 通过分子对接来研究自然化合物与MPXV受体的相互作用.
- 为了评估选择的植物化学品对MPXV受体的结合亲和力.
- 探索这些相互作用的潜在免疫调节和抗炎相关性.
主要方法:
- 用分子对接模拟来评估天然化合物的与MPXV受体的结合潜力.
- 各种植物化学物质的结合亲缘关系与参考药物Cidofovir进行了比较.
- 通过详细的分子相互作用分析确定了参与相互作用的关键结合残留物.
主要成果:
- 库库比他I和库库比他E表现出最强的结合亲缘关系,表现优于cidofovir.
- 库库比他素I表现出最有利的相互作用特征,其次是库库比他素E,皮皮林,蒂摩尔,卡瓦克罗尔和素.
- 在MPXV受体部位内确定了特定的结合残留物 (ALA2,ALA4,TRP24,ASP32,LEU101,THR133,ASN).
结论:
- 选择的天然化合物,特别是甲I和E,显示出与MPXV受体相互作用的显著潜力.
- 已识别的植物化学物质具有固有的免疫调节和抗炎性质,表明其具有双重治疗作用.
- 这些发现为开发新的基于植物化学的治疗策略提供了分子基础,用于治疗MPXV等与炎症相关的病毒性疾病.
相关概念视频
Cross-reactivity
32.7K
Overview
32.7K
Pharmacodynamics: Overview and Principles
2.7K
Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
2.7K
Drug-Receptor Interactions
7.2K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.2K
Opioid Receptors: Overview
3.8K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
3.8K
Agonism and Antagonism: Quantification
935
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
935
Drug-Receptor Interaction: Agonist
3.7K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
3.7K


